4VIGenomtec4VI info
$1.64info-4.29%24h
Global rank30235
Market cap$19.32M
Change 7d-4.29%
YTD Performance-34.49%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    Genomtec (4VI) Stock Overview

    Genomtec S.A. researches, develops, manufactures, and commercializes innovative molecular diagnostic products in optical systems and isothermal nucleic acid amplification methods in Poland and internationally. The company develops Genomtec ID, a technological device that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analyzing the biological material of patients using swabs, urine samples, saliva, blood, and other body fluids. It also develops Genomtec Tumor, a SNAAT based solution used to identify neoplastic mutations and mutations with prognostic value in neoplastic disease; Genomtec SARS-CoV-2 EvaGreen and Direct-RT-LAMP CE-IVD Kit to detect SARS-CoV-2 RNA in various biological samples from patients with suspected COVID-19 infection; and Genomtec RT-LAMP CE-IVD Duo-Kit for the detection of all variants of the SARS-CoV-2 virus. Genomtec S.A was founded in 2016 and is based in Wroclaw, Poland.

    4VI Stock Information

    Symbol
    4VI
    Address
    Bierutowska Street 57-59Wroclaw, 51-317Poland
    Founded
    -
    Trading hours
    -
    Website
    https://www.genomtec.com
    Country
    🇵🇱 Poland
    Phone Number
    48 793 440 931

    Genomtec (4VI) Price Chart

    -
    Value:-

    Genomtec Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.64
    N/A
    Market Cap
    $19.32M
    N/A
    Shares Outstanding
    11.80M
    N/A
    Employees
    18.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org